Henriksson; Krister
Patent Applications and Registrations
Patent applications and USPTO patent grants for Henriksson; Krister.The latest application filed is for "non-steroidal glucocorticoid receptor modulators for local drug delivery".
- Henriksson; Krister - Ballerup DK
- Henriksson; Krister - Lund SE
- Henriksson; Krister - AstraZeneca R&D Lund SE
- Henriksson, Krister - Svedala SE
| Patent | Date |
|---|---|
| Non-steroidal glucocorticoid receptor modulators for local drug delivery Grant 10,494,363 - Johnson , et al. De | 2019-12-03 |
| Non-steroidal Glucocorticoid Receptor Modulators For Local Drug Delivery App 20180258080 - JOHNSON; Patrick Stephen ; et al. | 2018-09-13 |
| Chemical Compounds 572 App 20120252770 - Berger; Markus ; et al. | 2012-10-04 |
| Chemical compounds 572 Grant 8,143,290 - Berger , et al. March 27, 2 | 2012-03-27 |
| Chemical Compounds App 20120065173 - Berger; Markus ; et al. | 2012-03-15 |
| Indazolyl sulphonamide derivatives useful as glucocorticoid modulators Grant 8,030,340 - Berger , et al. October 4, 2 | 2011-10-04 |
| Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases App 20110130426 - Bladh; Hakan ; et al. | 2011-06-02 |
| Chemical Compounds 572 App 20110071194 - Berger; Markus ; et al. | 2011-03-24 |
| Chemical Compounds 572 App 20100197644 - Berger; Markus ; et al. | 2010-08-05 |
| Chemical compounds 572 Grant 7,728,030 - Berger , et al. June 1, 2 | 2010-06-01 |
| 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 Grant 7,662,845 - Henriksson , et al. February 16, 2 | 2010-02-16 |
| Novel Bicyclic Sulfonamides for Use as Glucocorticoid Receptor Modulators in the Treatment of Inflammatory Diseases App 20090124607 - Bladh; Hakan ; et al. | 2009-05-14 |
| Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases App 20090093485 - Bladh; Hakan ; et al. | 2009-04-09 |
| Novel 5,6-Dihydropyrazolo[3,4-E] [L,4]Diazepin-4 (IH) -One Derivatives for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease App 20090054413 - Henriksson; Krister ; et al. | 2009-02-26 |
| Chemical compounds 572 App 20080214641 - Berger; Markus ; et al. | 2008-09-04 |
| Chemical compounds App 20080207721 - Berger; Markus ; et al. | 2008-08-28 |
| 2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12 Grant 7,354,940 - Henriksson , et al. April 8, 2 | 2008-04-08 |
| 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 App 20060276524 - Henriksson; Krister ; et al. | 2006-12-07 |
| Compounds Grant 7,005,439 - Eriksson , et al. February 28, 2 | 2006-02-28 |
| 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12 App 20050245586 - Henriksson, Krister ; et al. | 2005-11-03 |
| Novel compounds App 20050239801 - Eriksson, Tomas ; et al. | 2005-10-27 |
| Hydroxyalkyl compounds Grant 6,943,188 - Eriksson , et al. September 13, 2 | 2005-09-13 |
| Novel compounds App 20030153555 - Eriksson, Tomas ; et al. | 2003-08-14 |
| Novel compounds App 20030149047 - Eriksson, Tomas ; et al. | 2003-08-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 